CASE REPORT |
|
Year : 2019 | Volume
: 2
| Issue : 2 | Page : 104-106 |
|
Platelet-rich plasma protocols can potentiate vascular emboli: Contraindications to platelet-rich plasma
Prathap Jayaram1, Peter C Yeh2, John Cianca3
1 H. Ben Taub Department of Physical Medicine and Rehabilitation; Department of Orthopedic Surgery, Baylor College of Medicine, Houston, TX, USA 2 H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, USA 3 H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine; Department of Physical Medicine and Rehabilitation, The University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston; Human Performance Center, Bellaire, TX, USA
Correspondence Address:
Dr. Prathap Jayaram Baylor College of Medicine, Houston, TX USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jisprm.jisprm_48_19
|
|
Platelet-rich plasma (PRP) is a regenerative therapy strategy used to address surgical wounds, dermatological conditions, and musculoskeletal conditions, such as lateral epicondylosis. However, there exists significant uncertainty and speculation about antiplatelet agents' effects on PRP and optimal approaches to cessation of agents such as aspirin prior to PRP therapy. We present a rare case report that provides an example of temporary antiplatelet agent cessation complications in the context of a PRP therapy regimen for lateral epicondylosis, which was followed by microemboli to the brain. Given Class B evidence for PRP for lateral epicondylosis, we feel that this case of a nontraumatic brain injury sequelae can present more frequently given the increased popularity of this regenerative strategy, particularly if certain precautions are not evaluated.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|